aHSP Antikörper
Kurzübersicht für aHSP Antikörper (ABIN1387096)
Target
Alle aHSP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- AHSP Polyclonal Antibody
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human AHSP/ERAF
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:500-2000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- aHSP (alpha Hemoglobin Stabilizing Protein (aHSP))
-
Andere Bezeichnung
- AHSP
-
Hintergrund
-
Synonyms: AHSP, AHSP_HUMAN, Alpha hemoglobin stabilizing protein, Alpha-hemoglobin-stabilizing protein, EDRF, ERAF, Erythroid associated factor, Erythroid dferentiation associated factor, Erythroid dferentiation related factor, Erythroid dferentiation-related factor, Erythroid-associated factor.
Background: Act as a chaperone to prevent the harmful aggregation of alpha-hemoglobin during normal erythroid cell development. Specifically protects free alpha-hemoglobin from precipitation. It is predicted to modulate pathological states of alpha-hemoglobin excess such as beta-thalassemia.
Target
-